Clinical Trials Directory

Trials / Completed

CompletedNCT01496183

Metabolic Effects of Olanzapine in Healthy Males

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
State University of New York at Buffalo · Academic / Other
Sex
Male
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to look at how a two-week use of a medication called Olanzapine might change appetite, physical activity, resting metabolic rate, body composition, and weight in healthy men.

Conditions

Interventions

TypeNameDescription
DRUGOlanzapineOlanzapine 5mg capsule administered orally at bedtime for 7 days followed by Olanzapine 10 mg capsule administered orally at bedtime for 7 days.
DRUGPlaceboPlacebo capsule administered orally at bedtime for 14 days

Timeline

Start date
2007-10-01
Primary completion
2013-04-01
Completion
2013-04-01
First posted
2011-12-21
Last updated
2018-08-16
Results posted
2014-12-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01496183. Inclusion in this directory is not an endorsement.